Xie B, Wu P, Liu H, Yang X, Huang L
J Transl Med. 2025; 23(1):165.
PMID: 39920781
PMC: 11806857.
DOI: 10.1186/s12967-025-06128-8.
Herbst E, Mandel-Gutfreund Y, Yakhini Z, Biran H
Commun Biol. 2025; 8(1):87.
PMID: 39827321
PMC: 11743151.
DOI: 10.1038/s42003-025-07454-9.
Chen Z, Du Y, Shi H, Dong S, He R, Zhou W
Transl Cancer Res. 2024; 13(8):4113-4130.
PMID: 39262472
PMC: 11385540.
DOI: 10.21037/tcr-24-51.
Chen Z, Guan D, Zhu Q, Wang Z, Han F, Zhou W
Curr Issues Mol Biol. 2023; 45(11):8864-8881.
PMID: 37998733
PMC: 10670187.
DOI: 10.3390/cimb45110556.
Pei L, Yan D, He Q, Kong J, Yang M, Ruan H
Cell Oncol (Dordr). 2023; 46(5):1509-1527.
PMID: 37355516
PMC: 10618329.
DOI: 10.1007/s13402-023-00826-5.
The non-coding RNA (ncRNA)-mediated high expression of polycomb group factor 1 (PCGF1) is a prognostic biomarker and is correlated with tumor immunity infiltration in liver hepatocellular carcinoma.
Liu J, Xu Y, Sun C, Yang S, Xie J, Samant H
Ann Transl Med. 2022; 10(16):898.
PMID: 36111035
PMC: 9469147.
DOI: 10.21037/atm-22-3862.
LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
Ke J, Wang Q, Zhang W, Ni S, Mei H
Am J Transl Res. 2022; 14(8):5441-5454.
PMID: 36105009
PMC: 9452358.
Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities.
Kulkarni A, Gayathrinathan S, Nair S, Basu A, Al-Hilal T, Roy S
Cells. 2022; 11(15).
PMID: 35954293
PMC: 9367924.
DOI: 10.3390/cells11152448.
High expression of RRM2 mediated by non-coding RNAs correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
Mao G, Li L, Shan C, Liang B, Ma L, Zhang S
Front Med (Lausanne). 2022; 9:833301.
PMID: 35911380
PMC: 9330188.
DOI: 10.3389/fmed.2022.833301.
Transcriptomic Analyses Reveal Long Non-Coding RNA in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Kunadirek P, Pinjaroen N, Nookaew I, Tangkijvanich P, Chuaypen N
Int J Mol Sci. 2022; 23(14).
PMID: 35887228
PMC: 9324406.
DOI: 10.3390/ijms23147882.
Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils.
Yu H, Chen C, Han F, Tang J, Deng M, Niu Y
Cancer Immunol Res. 2022; 10(9):1095-1110.
PMID: 35862232
PMC: 9433964.
DOI: 10.1158/2326-6066.CIR-21-1011.
MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.
Zhong C, Xie Z, Zeng L, Yuan C, Duan S
Front Immunol. 2022; 13:855078.
PMID: 35784328
PMC: 9240468.
DOI: 10.3389/fimmu.2022.855078.
Construction of a Prognostic Model for Hypoxia-Related LncRNAs and Prediction of the Immune Landscape in the Digestive System Pan-Cancer.
He Z, Liu H, Guan H, Ji J, Jiang Y, Zhang N
Front Oncol. 2022; 12:812786.
PMID: 35574385
PMC: 9092832.
DOI: 10.3389/fonc.2022.812786.
High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.
Mao G, Shan C, Li W, Liang B, Ma L, Zhang S
Int J Gen Med. 2022; 15:2607-2620.
PMID: 35282644
PMC: 8910518.
DOI: 10.2147/IJGM.S353362.
Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
Zhang L, Hu S, Chen J, Ma S, Liu F, Liu C
Discov Oncol. 2022; 12(1):38.
PMID: 35201491
PMC: 8777520.
DOI: 10.1007/s12672-021-00436-3.
Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma.
Mo M, Liu B, Luo Y, Juan Tan J, Zeng X, Zeng X
Front Mol Biosci. 2022; 9:801478.
PMID: 35141281
PMC: 8819184.
DOI: 10.3389/fmolb.2022.801478.
Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling.
Zheng W, Shen G, Xu K, Yin Q, Hui T, Zhou Z
World J Gastrointest Oncol. 2022; 14(1):253-264.
PMID: 35116115
PMC: 8790426.
DOI: 10.4251/wjgo.v14.i1.253.
ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
Pan G, Zhang J, You F, Cui T, Luo P, Wang S
Bioengineered. 2022; 13(1):1346-1358.
PMID: 34983308
PMC: 8805956.
DOI: 10.1080/21655979.2021.2017565.
Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma.
Wu Z, Li Z, Yang D, Liu J
Front Cell Dev Biol. 2021; 9:713925.
PMID: 34869306
PMC: 8634266.
DOI: 10.3389/fcell.2021.713925.
lncRNA MIR4435‑2HG promotes the progression of liver cancer by upregulating B3GNT5 expression.
Zhu Y, Li B, Xu G, Han C, Xing G
Mol Med Rep. 2021; 25(1).
PMID: 34859256
PMC: 8669657.
DOI: 10.3892/mmr.2021.12554.